Follicle-stimulating hormone is associated with low bone mass in postmenopausal women. Mattick LJ, Bea JW, Hovey KM, Wactawski-Wende J, et al. Osteoporos Int 2023;34:693-701.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mattick LJ, Bea JW, Hovey KM, Wactawski-Wende J, et al. Follicle-stimulating hormone is associated with low bone mass in postmenopausal women. Osteoporos Int 2023;34:693-701.
PMID: 36692543